Speciality

BMT/SCT

Product: MozobilĀ® plerixafor

Disease: Bone marrow Transplantation

Indication: Indicated in combination with G-CSF to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma whose cells mobilise poorly

Product: Anti-thymocyte Globulin (Rabbit)

Disease: Bone marrow Transplantation

Indication: Indicated for the treatment of renal transplant acute rejection in conjunction with concomitant immunosuppression.